Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases.
Changes in the oxidative status of erythrocytes can reduce cell lifetime, oxygen transport, and delivery capacity to peripheral tissues and have been associated with a plethora of human diseases. Among reactive oxygen and nitrogen species of importance in red blood cell (RBC) homeostasis, superoxide and nitric oxide radicals play a key role. In the present work, we evaluated subcellular effects induced by peroxynitrite, the product of the fast reaction between superoxide and nitric oxide. Peroxynitrite induced 1) oxidation of oxyhemoglobin to methemoglobin, 2) cytoskeleton rearrangement, 3) ultrastructural alterations, and 4) altered expression of band-3 and decreased expression of glycophorin A. With respect to control cells, this occurred in a significantly higher percentage of human RBC (approximately 40%). The presence of antioxidants inhibited these modifications. Furthermore, besides these senescence-associated changes, other important modifications, absent in control RBC and usually associated with apoptotic cell death, were detected in a small but significant subset of peroxynitrite-exposed RBC (approximately 7%). Active protease cathepsin E and mu-calpain increased; activation of caspase 2 and caspase 3 was detected; and phosphatidylserine externalization, an early marker of apoptosis, was observed. Conversely, inhibition of cathepsin E, mu-calpain, as well as caspase 2 and 3 by specific inhibitors resulted in a significant impairment of erythrocyte "apoptosis" Altogether, these results indicate that peroxynitrite, a milestone of redox-mediated damage in human pathology, can hijack human RBC toward senescence and apoptosis by a mechanism involving both cysteinyl and aspartyl proteases.
Matarrese
Paola
P
Department of Drug Research and Evaluation, Istituto Superiore di Sanita, Rome 00161, Italy.
Straface
Elisabetta
E
Pietraforte
Donatella
D
Gambardella
Lucrezia
L
Vona
Rosa
R
Maccaglia
Alessandro
A
Minetti
Maurizio
M
Malorni
Walter
W
D001457:Anion Exchange Protein 1, Erythrocyte / Q000032:analysis; D017209:Apoptosis / Q000187:drug effects*; D016282:Aspartic Acid Endopeptidases / Q000097:blood*; D002154:Calpain / Q000097:blood; D020169:Caspases / Q000097:blood; D020059:Cathepsin E / Q000097:blood; D003546:Cysteine Endopeptidases / Q000097:blood*; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology* / Q000648:ultrastructure; D005978:Glutathione / Q000097:blood; D006021:Glycophorins / Q000032:analysis; D006801:Humans; D008706:Methemoglobin / Q000032:analysis*; D008855:Microscopy, Electron, Scanning; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D030421:Peroxynitrous Acid / Q000493:pharmacokinetics*; D010718:Phosphatidylserines / Q000097:blood
D001457:Anion Exchange Protein 1, Erythrocyte; D006021:Glycophorins; D010718:Phosphatidylserines; D030421:Peroxynitrous Acid; D008706:Methemoglobin; D002154:Calpain; D020169:Caspases; D003546:Cysteine Endopeptidases; D016282:Aspartic Acid Endopeptidases; D020059:Cathepsin E; D005978:Glutathione